B
Bryce R. Taylor
Researcher at University Health Network
Publications - 76
Citations - 10560
Bryce R. Taylor is an academic researcher from University Health Network. The author has contributed to research in topics: Liver transplantation & Hepatectomy. The author has an hindex of 38, co-authored 76 publications receiving 9911 citations. Previous affiliations of Bryce R. Taylor include Toronto General Hospital & University of Toronto.
Papers
More filters
Journal ArticleDOI
Periampullary tumors: which ones should be resected?
TL;DR: Resection was carried out in 118 patients for periampullary lesions and 90 of these were adenocarcinomas and were treated by the Whipple operation, total pancreatectomy, or local resection.
Journal ArticleDOI
Further Report of a Prospective Randomized Trial Comparing Distal Splenorenal Shunt With End-to-Side Portacaval Shunt An Analysis of Encephalopathy, Survival, and Quality of Life
Bernard Langer,Bernard Langer,Bernard Langer,Bryce R. Taylor,Bryce R. Taylor,Bryce R. Taylor,D.R. Mackenzie,D.R. Mackenzie,D.R. Mackenzie,T. Gilas,T. Gilas,T. Gilas,Richard Stone,Richard Stone,Richard Stone,Laurence M. Blendis,Laurence M. Blendis,Laurence M. Blendis +17 more
TL;DR: The distal splenorenal ("selective") shunt with the end-to-side portacaval shunt was electively compared in 80 prospectively randomized patients with variceal bleeding to find out whether selective shunts protected well against late gastrointestinal bleeding or not.
Journal ArticleDOI
Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation
Alan W. Hemming,Bernard Langer,Paul D. Greig,Bryce R. Taylor,Reid B. Adams,E. Jennifer Heathcote +5 more
TL;DR: Both PSS and LT are effective options in the management of Budd-Chiari syndrome and portosystemic shunt is the preferred initial approach even with cirrhosis or retrohepatic caval compression as long as there is preservation of liver function and a patent vena cava.
Journal ArticleDOI
Complications after peritoneovenous shunting for ascites
TL;DR: Because of the significant morbidity and mortality associated with the peritoneovenous shunt, it is recommended only for patients with massive intractable hepatic ascites whose condition is refractory to maximal medical therapy.
Journal Article
Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach.
TL;DR: An aggressive approach to resection of bile duct tumors is possible with a low operative mortality rate and offers the best opportunity for cure as well as good palliation.